Related Experiment Video
Updated: Jun 20, 2026

Treatment of Platelet Products with Riboflavin and UV Light: Effectiveness Against High Titer Bacterial Contamination
Published on: August 24, 2015
Problem of bacterial contamination in platelet concentrates
1Department of Transfusion Medicine, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Trivandrum, Kerala, India. jaisym@sctimst.ac.in
Bacterial contamination in blood transfusions is a growing concern. Enhancing donor screening, storage, and detection methods is crucial for improving blood safety and reducing patient complications.
Area of Science:
- Transfusion Medicine
- Infectious Diseases
- Hematology
Background:
- Bacterial contamination of blood products is an increasingly recognized complication of transfusions.
- While current safety measures have reduced risks, bacterial contamination remains a significant concern.
- Bacteraemia can be linked to acute or subacute infections in donors, necessitating rigorous selection criteria.
Purpose of the Study:
- To highlight the importance of bacterial contamination in blood transfusions.
- To discuss current and future strategies for mitigating transfusion-related bacterial risks.
- To emphasize the role of haemovigilance and clinical awareness in patient safety.
Main Methods:
- Review of current practices in blood collection, storage, and transfusion.
- Discussion of the impact of storage time on bacterial load and endotoxin levels.
- Exploration of advancements in bacterial detection and pathogen reduction technologies.
Main Results:
- Bacterial contamination is a serious transfusion complication, with risks not fully eliminated by current standards.
- Increased storage time correlates with higher bacterial counts and endotoxin levels, potentially causing transfusion reactions.
- Haemovigilance and clinician awareness are vital for reducing patient morbidity.
Conclusions:
- Strict donor selection and adherence to collection/storage standards are essential.
- Further advancements in bacterial detection, pathogen reduction, and platelet biology are needed to enhance blood product safety.
- Improved haemovigilance systems and clinical awareness are critical for minimizing complications.
More Related Videos
12:40Preparation and Pathogen Inactivation of Double Dose Buffy Coat Platelet Products using the INTERCEPT Blood System
Published on: December 7, 2012
05:49Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets
Published on: November 29, 2024